Trial intelligence / Profile preview

Bimatoprost for Eyelash Hypotrichosis in African Americans

NCT00958035Phase 4Completed

Sponsor
Allergan
Start
Nov 2009
Primary completion
Jul 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of bimatoprost in Eyelash Hypotrichosis, sponsored by Allergan. Started Nov 2009; status: completed.

02

Drugs

bimatoprost
03

Conditions

Eyelash Hypotrichosis

Beyond the preview

Go deeper on NCT00958035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00958035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call